These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 18990887

  • 1. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
    MMW Fortschr Med; 2008 Oct 02; 150(40):52-3. PubMed ID: 18990887
    [No Abstract] [Full Text] [Related]

  • 2. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
    MMW Fortschr Med; 2007 Dec 06; 149(49-50):58. PubMed ID: 18236985
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].
    MMW Fortschr Med; 2009 Jan 29; 151(5):46-7. PubMed ID: 19391415
    [No Abstract] [Full Text] [Related]

  • 4. [Proton pump inhibition: more than only reflux therapy].
    MMW Fortschr Med; 2008 Nov 13; 150(46):48-9. PubMed ID: 19133361
    [No Abstract] [Full Text] [Related]

  • 5. [Cost comparative analysis of drug therapy for non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer in Japan].
    Hashiguchi M, Yamauchi N, Uchikura T, Mochizuki M.
    Yakugaku Zasshi; 2008 Apr 13; 128(4):585-94. PubMed ID: 18379175
    [Abstract] [Full Text] [Related]

  • 6. Generics offer pharmacy plans specific benefits.
    Reinke T.
    Manag Care; 2010 Feb 13; 19(2):28-30, 34. PubMed ID: 20550049
    [No Abstract] [Full Text] [Related]

  • 7. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
    Calabrese C, Liguori G, Gabusi V, Gionchetti P, Rizzello F, Straforini G, Brugnera R, Di Febo G.
    Aliment Pharmacol Ther; 2008 Jul 13; 28(2):250-5. PubMed ID: 18485128
    [Abstract] [Full Text] [Related]

  • 8. [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
    Mouly S, Charlemagne A, Le Jeunne P, Fagnani F.
    Presse Med; 2008 Oct 13; 37(10):1397-406. PubMed ID: 18502602
    [Abstract] [Full Text] [Related]

  • 9. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women.
    Prescrire Int; 2009 Dec 13; 18(104):250. PubMed ID: 20025090
    [Abstract] [Full Text] [Related]

  • 10. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L.
    Lakartidningen; 2009 Dec 13; 106(8):502-5. PubMed ID: 19350782
    [No Abstract] [Full Text] [Related]

  • 11. The acid test for formulary policy.
    McCaffrey E.
    Bus Health; 1999 Dec 13; 17(12 Suppl A):19-24. PubMed ID: 10747676
    [No Abstract] [Full Text] [Related]

  • 12. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
    van Hout BA, Klok RM, Brouwers JR, Postma MJ.
    Clin Ther; 2003 Feb 13; 25(2):635-46. PubMed ID: 12749518
    [Abstract] [Full Text] [Related]

  • 13. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
    Foroutan N, Fahimi F, Dabiri Y, Foroutan A, Habibi M, Salamzadeh J.
    J Popul Ther Clin Pharmacol; 2015 Dec 31; 22(3):e292-e302. PubMed ID: 28414416
    [Abstract] [Full Text] [Related]

  • 14. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW, Ballard ED, Koch FK, Gautille TC, Bagin RG.
    J Clin Gastroenterol; 2009 Apr 31; 43(4):323-6. PubMed ID: 18758373
    [Abstract] [Full Text] [Related]

  • 15. [Drug treatment and surgical indications in gastroesophageal reflux].
    Pérez-Manauta J.
    Rev Gastroenterol Mex; 2007 Nov 31; 72 Suppl 2():13-6. PubMed ID: 18277473
    [No Abstract] [Full Text] [Related]

  • 16. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR.
    Expert Rev Gastroenterol Hepatol; 2007 Dec 31; 1(2):197-205. PubMed ID: 19072410
    [Abstract] [Full Text] [Related]

  • 17. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB, McKean LA, Gibb RD, Erasala GN, Ramsey DL, McRorie JW.
    Aliment Pharmacol Ther; 2010 Apr 31; 31(8):846-51. PubMed ID: 20146702
    [Abstract] [Full Text] [Related]

  • 18. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH, Kim MJ, Lee JS, Choe YH.
    Arch Dis Child; 2011 Jan 31; 96(1):9-13. PubMed ID: 20870626
    [Abstract] [Full Text] [Related]

  • 19. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
    Morreale A.
    Manag Care Interface; 2001 Jan 31; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
    [No Abstract] [Full Text] [Related]

  • 20. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
    Curtiss FR.
    J Manag Care Pharm; 2004 Jan 31; 10(5):458-60. PubMed ID: 15369431
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.